Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
how long does tricare cover semaglutide New VA Clinical Trial Examines GLP-1s Can Help Treat 400K Veterans With Alcohol Use Disorder collection_gut-health Ozempic: GLP-1 muscle loss Purchase Type:MB-1 | 1 Month Delivery
Ozempic: GLP-1 muscle loss may not be as high as thought
This improves portion control and satisfaction
collection_gut-health
Purchase Type:MB-1 | 1 Month Delivery
6.2 Novo Nordisk + Septerna (May 2025, up to $2.2B) Novo's second major triple-agonist transaction was a broader small-molecule GPCR collaboration with Septerna announced May 2025: up to $2.2 billion total deal value, $200 million+ upfront, covering four oral small-molecule GPCR programs
US$ 26.32
US$ 24.74
US$ 25.29
US$ 21.37
US$ 23.97
US$ 20.31
